Tenon Medical Statistics
Total Valuation
Tenon Medical has a market cap or net worth of $8.12 million. The enterprise value is $2.01 million.
Important Dates
The next confirmed earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Tenon Medical has 6.20 million shares outstanding. The number of shares has increased by 434.80% in one year.
| Current Share Class | 6.20M |
| Shares Outstanding | 6.20M |
| Shares Change (YoY) | +434.80% |
| Shares Change (QoQ) | +259.06% |
| Owned by Insiders (%) | 0.34% |
| Owned by Institutions (%) | 2.69% |
| Float | 6.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| Forward PS | 1.13 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 3.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.39 |
| Quick Ratio | 3.96 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -404.88 |
Financial Efficiency
Return on equity (ROE) is -405.19% and return on invested capital (ROIC) is -190.47%.
| Return on Equity (ROE) | -405.19% |
| Return on Assets (ROA) | -106.30% |
| Return on Invested Capital (ROIC) | -190.47% |
| Return on Capital Employed (ROCE) | -172.64% |
| Revenue Per Employee | $121,370 |
| Profits Per Employee | -$506,407 |
| Employee Count | 27 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.70 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.58% in the last 52 weeks. The beta is 1.24, so Tenon Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -81.58% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 2.65 |
| Relative Strength Index (RSI) | 54.16 |
| Average Volume (20 Days) | 373,680 |
Short Selling Information
The latest short interest is 165,429, so 2.67% of the outstanding shares have been sold short.
| Short Interest | 165,429 |
| Short Previous Month | 140,680 |
| Short % of Shares Out | 2.67% |
| Short % of Float | 2.68% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, Tenon Medical had revenue of $3.28 million and -$13.67 million in losses. Loss per share was -$11.26.
| Revenue | 3.28M |
| Gross Profit | 1.71M |
| Operating Income | -13.77M |
| Pretax Income | -14.33M |
| Net Income | -13.67M |
| EBITDA | -13.36M |
| EBIT | -13.77M |
| Loss Per Share | -$11.26 |
Full Income StatementBalance Sheet
The company has $6.54 million in cash and $428,000 in debt, giving a net cash position of $6.11 million or $0.99 per share.
| Cash & Cash Equivalents | 6.54M |
| Total Debt | 428,000 |
| Net Cash | 6.11M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 5.97M |
| Book Value Per Share | 0.71 |
| Working Capital | 6.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.88 million and capital expenditures -$186,000, giving a free cash flow of -$10.06 million.
| Operating Cash Flow | -9.88M |
| Capital Expenditures | -186,000 |
| Free Cash Flow | -10.06M |
| FCF Per Share | -$1.62 |
Full Cash Flow StatementMargins
| Gross Margin | 52.21% |
| Operating Margin | -420.08% |
| Pretax Margin | -417.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Tenon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -434.80% |
| Shareholder Yield | -434.80% |
| Earnings Yield | -168.35% |
| FCF Yield | -123.91% |
Analyst Forecast
The average price target for Tenon Medical is $11.67, which is 790.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.67 |
| Price Target Difference | 790.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on September 6, 2024. It was a reverse split with a ratio of 0.125:1.
| Last Split Date | Sep 6, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.125:1 |
Scores
Tenon Medical has an Altman Z-Score of -12.79 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.79 |
| Piotroski F-Score | 4 |